Sustained long-term benefit of sildenafil in primary pulmonary hypertension

Sayin T., Ozenci M.

ACTA CARDIOLOGICA, cilt.62, sa.1, ss.47-49, 2007 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 62 Sayı: 1
  • Basım Tarihi: 2007
  • Doi Numarası: 10.2143/ac.62.1.2019370
  • Dergi Adı: ACTA CARDIOLOGICA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.47-49
  • Anahtar Kelimeler: sildenafil, pulmonary hypertension, INHALED ILOPROST, ORAL SILDENAFIL
  • Ankara Üniversitesi Adresli: Hayır

Özet

Primary pulmonary hypertension is a rare disease with an ominous prognosis for which new therapeutic options are being developed. Recently, there have been case reports indicating that sildenafil may be of benefit in short-to midterm follow-up. However, long-term clinical data of sildenafil in primary pulmonary hypertensive patients is lacking. We report a patient with primary pulmonary hypertension treated with sildenafil 200 mg/day for 50 months with a sustained clinical response.